This website is published by ARCHIMED SAS, a simplified joint stock company with a share capital of 175,000 euros, entered in the Lyon trade and companies register under number 795 309 525 and whose registered office is located at Silex², 9 rue des Cuirassiers, 69003 Lyon, France.

ARCHIMED SAS is an asset management company registered with Autorité des Marchés Financiers (AMF) under N° GP-14000002. ARCHIMED’s website is stored in France and is compliant regarding GDPR.

Email: contact@archimed.group

Telephone: +33 4 81 11 35 33

Publication Director: Denis Ribon

Host: France

VAT: FR90 795 309 525

These general terms and conditions of use govern the use of the website accessible at the URL https://www.archimed.group/.

The archimed.group website is accessible to anyone who wishes to learn about the services offered by ARCHIMED SAS.

Account: Refers to the means by which Identified Users can access their Investor Space by identifying themselves using an identifier and a password.

Terms and Conditions: Refers to these general terms and conditions of use.

Content: Refers to items posted online by Users, in particular messages, comments, etc.

Website: Refers to the archimed.group website available at https://www.archimed.group/.

Website Owner: Refers to ARCHIMED SAS, entered in the Lyon trade and companies register under number 795 309 525.

User: Refers to any natural person or legal entity using the Website, including the Identified User.

Identified User: Refers to any natural person or legal entity holding an Account on the Website and using the Website.

Website Owner: ARCHIMED SAS, a simplified joint stock company with a share capital of 175,000 euros, entered in the Lyon trade and companies register under number 795 309 525 and whose registered office is located at Silex², 9 rue des Cuirassiers, 69003 Lyon, France, acting through its current legal representatives.

Publication Director: Denis Ribon.

Host: France

The purpose of the Terms and Conditions is to define the rights and obligations of the Website Owner and the User in accessing and using the Website.

The Website allows Users to learn about the services offered by ARCHIMED SAS, view the investments that they have made as investors, and contact ARCHIMED SAS.

Access to the Website requires that the Users access a telecommunications network. This access is provided by a telecommunications operator, and access is the sole responsibility of the User.

In accessing the Website, Users are prohibited from engaging in any behaviour that could affect the image of the Website Owner or of one or more other Users.

The Website and each of its components, including the graphic charter, data, software, texts, and logos of the Website, are protected by intellectual property law, in particular copyright, rights with regard to drawings and models, and/or trademark rights.

The Website and each of its components are the exclusive property of the Website Owner.

The Website Owner grants the User a private, non-exclusive right to use the Website in accordance with the stipulations of these Terms and Conditions.

Any other use of the Website or any of its components constitutes an infringement of rights and is punishable under the French intellectual property code, except with the Website Owner’s express prior consent.

Information that we collect undergoes processing of personal data in accordance with the GDPR, regulation no. 2016/679. This processing is performed by ARCHIMED SAS, a simplified joint stock company with a share capital of 175,000 euros, entered in the Lyon trade and companies register under number 795 309 525 and whose registered office is located at Silex², 9 rue des Cuirassiers, 69003 Lyon, France.

This processing is intended to enable ARCHIMED SAS to manage the customer relationship, create a dedicated Investor Space and transmit information related to its’ activity and services. The recipients of the data shall be limited exclusively to the Website Owner. Such data shall be stored for no longer than the duration necessary for the purpose for which it was collected, and in any case no more than three (3) years from the last established contact.

ARCHIMED SAS is concerned with protecting your personal data and has implemented measures to ensure the security, confidentiality, and integrity such data.

The private policy is available to the investors at the headquarters of the company.

In accordance with the regulations, at any time, you may exercise your right of access, correction, deletion, limitation, and portability, where applicable, for information concerning you by contacting ARCHIMED SAS at the following address: Silex², 9 rue des Cuirassiers, 69003 Lyon, France / contact@archimed.group. If you exercise your right to object to the use of personal data that we have about you, and if such data is necessary to use our services, you shall no longer be able to use our services.

If necessary, you may also lodge a complaint with the CNIL (French National Data Protection Commission). Before doing so, we urge you to contact our data protection representative at dpo@archimed.group, who shall respond to you within one (1) month.

ARCHIMED is committed to sustainable development and responsible investing.

We are convinced that being accountable to environmental, social and governance issues allows us to reduce risks, to make better investment decisions and to contribute in the building of strong companies, all the while improving the value we create for our investors.

We believe that sharing our ESG values with our portfolio companies will allow us to build stronger brands, in order to further optimize operational efficiencies, reduce costs, boost team productivity, access potential new markets, lower the cost of capital and raise our portfolio companies’ profitabity and their shareholders’ returns.

From its inception in 2014, ARCHIMED has signed the “Charte d’Engagements des Investisseurs pour la croissance”, established by France Invest. This Charter sets objectives that go beyond the traditional financial, ethical and regulatory topics: economic, environmental, social and governance.

We have integrated within our due diligence process an ESG (Environmental, Social and Governance) process. This initiative is fundamental to our overall investment strategy. We are convinced that the integration of non-financial elements in our investment strategy is essential in order to create long term value for our investors, our portfolio companies and our partners. We encourage the companies we invest in to adopt the best policies in this area. We have created within our management company an ESG improvement policy for our internal procedures in order for us to reduce our carbon footprint and so that we can improve our social and governmental impact.

We work alongside our portfolio companies to reduce our impact on the environment.

We apply the same environmentally conscious approach at the investment management company level through a set of policies that aim to reduce our environmental footprint when travelling, managing waste and in various other areas.

As an investment company specialised in healthcare, we participate in actions that promote individual and social wellbeing in France and in Europe.

We capitalize on our healthcare expertise, as well as on our access to capital to contribute to sustainable change. In accelerating growth and improving the positioning of our portfolio companies in the long term, we promote job creation and participation in local economies.

Within our portfolio companies, we establish better governance and strong reporting practices. Additionally, we aim to develop or reinforce their management teams’ ability to promote these practices, and we encourage them to share this information widely, in a transparent manner, throughout the entire length of the investment period.

The voting policy of the management company is available to the investors at the headquarters of the company.

The report on shareholder engagement policy describes the conditions under which ARCHIMED applied its voting and engagement policy.

ARCHIMED has implemented a « best selection/best execution » policy in order to act in the best interests of the investors.

Pursuant to regulatory requirements, ARCHIMED has set up a procedure for the prevention and management of conflicts of interest to ensure their identification, prevention and handling in order to avoid hammering the interests of clients.

The conflict of interest policy of the management company is available to the investors at the headquarters of the company.

ARCHIMED undertakes to acknowledge receipt of any claim within 48 hours, by any means. ARCHIMED undertakes to respond to any claim within a maximum period of 8 working days, except in case of the occurrence of duly justified specific circumstances.

You can send your claim to the attention of the Compliance Officer by email (co@archimed.group) or by regular mail at the following address: ARCHIMED SAS – Silex² – 9 rue des Cuirassiers- 69003 Lyon.

In case of dissatisfaction regarding the treatment of your claim, you can contact the independent mediator of the AMF at the following address :

Mediateur de l’AMF 7, place de la bourse 75082 Paris Cedex 02.

An electronic form is also available on the website:

www.amf-france.org